A while ago we reported about the successful trial treating Act-O2-Hem with UV-C light for the purpose of virus inactivation. The UV-C irradiation equipment has been designed and provided by Aquisense Technologies. A copy of the full report is available upon request.
A poster prepared by our scientists gives a sneak preview of the performed trials and their outcome.
